Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer treated by induction chemotherapy with or without oral low dose cyclophosphamide-methotrexate maintenance chemotherapy (CMM) / G. Pruneri, K.P.G.. - In: CANCER RESEARCH. - ISSN 0008-5472. - 76:suppl. 4(2016), pp. P2-08-02.1-P2-08-02.1. (38. Annual CTRC-AACR San Antonio Breast Cancer Symposium San Antonio 2015) [10.1158/1538-7445.SABCS15-P2-08-02].
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer treated by induction chemotherapy with or without oral low dose cyclophosphamide-methotrexate maintenance chemotherapy (CMM)
G. Pruneri;A. Vingiani;G. Viale;G. Curigliano;C. Criscitiello;M. Colleoni
2016
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Poster_compressed.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
61.49 kB
Formato
Adobe PDF
|
61.49 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
